1-20 of 24
Venkatraman Seshan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

Clinical Trials & Observations
David A. Qualls, Nicholas Lambert, Paolo F. Caimi, Mwanasha Merrill, Priyanka Pullarkat, Richard C. Godby, David A. Bond, Graham T. Wehmeyer, Jason Romancik, Behzad Amoozgar, Lori Leslie, Loretta J. Nastoupil, Jennifer L. Crombie, Jeremy S. Abramson, Arushi Khurana, Grzegorz S. Nowakowski, Kami Maddocks, Sarah C. Rutherford, Brad Kahl, Michelle Okwali, Michael J. Buege, Venkatraman Seshan, Connie L. Batlevi, Gilles Salles
Journal: Blood
Blood (2023) 142 (26): 2327–2331.
https://doi.org/10.1182/blood.2023021274
Published: 2023
Includes: Supplemental data
Journal Articles

Real-World Outcomes in Patients with Transformed Follicular Lymphoma Treated with CD19-Targeting CAR-T Therapy

Alfredo Rivas-Delgado, Efrat Luttwak, Esther Drill, Ilan Goldstein, Ivan Landego, Ana Alarcon Tomas, Allison Parascondola, Amethyst Saldia, Philip Caron, Parastoo B. Dahi, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paul A. Hamlin, William Johnson, Anita Kumar, Richard J. Lin, Jennifer Kimberly Lue, Colette Owens, Ariela Noy, Michael Scordo, Ahmet Dogan, Venkatraman Seshan, Andrew D. Zelenetz, Miguel-Angel Perales, Roni Shouval, Maria Lia Palomba, Gunjan L. Shah, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 4888.
https://doi.org/10.1182/blood-2023-187379
Published: 2023
Journal Articles

Outcomes of Sequential CD19-Directed Therapies in Relapsed and Refractory Large B Cell Lymphoma

David A Qualls, Nicholas Lambert, Paolo F. Caimi, Mwanasha Hamuza Merrill, Priyanka Pullarkat, Richard C. Godby, David A. Bond, Graham Wehmeyer, Jason T. Romancik, Behzad Amoozgar, Lori A. Leslie, Loretta J. Nastoupil, Jennifer L Crombie, Jeremy S. Abramson, Arushi Khurana, Grzegorz S. Nowakowski, Kami J. Maddocks, Sarah C. Rutherford, Brad S. Kahl, Michelle Okwali, Michael Buege, Venkatraman Seshan, Connie Wing-Ching Lee Batlevi, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 3136.
https://doi.org/10.1182/blood-2023-182204
Published: 2023
Journal Articles

A Multicenter Phase 2 Trial of Zanubrutinib, Obinutuzumab, and Venetoclax (BOVen) in Patients with Treatment-Naïve, TP53 -Mutant Mantle Cell Lymphoma

Anita Kumar, Jacob Soumerai, Jeremy S. Abramson, Jeffrey A. Barnes, Philip Caron, Maria Chabowska, Mary Devlin, Ahmet Dogan, Lorenzo Falchi, Rayna N. Garcia, Clare Grieve, Emma Haskell, Julie E. Haydu, Patrick Connor Johnson, Ashlee Joseph, Hailey E. Kelly, Alyssa Labarre, Emerald D Littlejohn, Jennifer Kimberly Lue, Joanna Mi, Rosalba Martignetti, Grace McCambridge, Alison Moskowitz, Colette Owens, Sean F. Plummer, Madeline G. Puccio, Gilles Salles, Venkatraman Seshan, Natalie Slupe, Andrew D. Zelenetz
Journal: Blood
Blood (2023) 142 (Supplement 1): 738.
https://doi.org/10.1182/blood-2023-180069
Published: 2023
Journal Articles

Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy

N. Ari Wijetunga, Emily Lebow, Alexander Chan, Beatrice Fregonese, Venkatraman Seshan, Carla Hajj, Gustav Cederquist, Harper Hubbeling, Jennifer Ma, Reith R Sarkar, Kathryn Tringale, Pallavi Galera, Erel Joffe, Ahmet Dogan, Hans-Guido Wendel, Andrew D. Zelenetz, Gilles Salles, Brandon S. Imber, Joachim Yahalom
Journal: Blood
Blood (2023) 142 (Supplement 1): 6099.
https://doi.org/10.1182/blood-2023-185338
Published: 2023
Journal Articles

Tafasitamab and Lenalidomide in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL): Real World Outcomes in a Multicenter Retrospective Study

David Qualls, Michael J Buege, Phuong Dao, Paolo F. Caimi, Sarah C. Rutherford, Graham Wehmeyer, Jason T. Romancik, Lori A. Leslie, Mwanasha H. Merrill, Jennifer L. Crombie, Behzad Amoozgar, Brad S. Kahl, David A. Bond, Kami J. Maddocks, Michelle Okwali, Venkatraman Seshan, Gilles Salles, Connie Lee Batlevi
Journal: Blood
Blood (2022) 140 (Supplement 1): 787–789.
https://doi.org/10.1182/blood-2022-167620
Published: 2022
Journal Articles

Molecular Profiling across Lymphoma Subtypes Using MSK-Impact Next Generation Sequencing

Connie Lee Batlevi, Esther Drill, Michelle Okwali, Ryan Ptashkin, Philip C Caron, Zachary D. Epstein-Peterson, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Anita Kumar, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, David J. Straus, Santosha Vardhana, Andrew D. Zelenetz, Maria E. Arcila, Ahmet Dogan, Venkatraman Seshan, Gilles Salles, Ahmet Zehir, Anas Younes
Journal: Blood
Blood (2022) 140 (Supplement 1): 9251–9253.
https://doi.org/10.1182/blood-2022-158783
Published: 2022
Journal Articles

Genetic Alterations of Crebbp Are Associated with Radiosensitivity in Follicular Lymphoma

Neil Ari Wijetunga, Emily S. Lebow, Jisun Lee, Beatrice Fregonese, Kathryn R. Tringale, Harper Hubbeling, Reith Sarkar, Jennifer Ma, Venkatraman Seshan, Erel Joffe, Ahmet Dogan, Alexander Chan, Guido Wendel, Carla Hajj, Brandon S. Imber, Joachim Yahalom
Journal: Blood
Blood (2022) 140 (Supplement 1): 6413–6414.
https://doi.org/10.1182/blood-2022-169501
Published: 2022
Journal Articles

BCL6 Rearranged Indolent B-Cell Lymphomas Show Mutational Profile Similar to Marginal Zone Lymphomas

Pallavi K Galera, David Qualls, Umut Aypar, Caroline Kostrzewa, Menglei Zhu, Jeeyeon Baik, Venkatraman Seshan, Gilles Salles, Ahmet Dogan
Journal: Blood
Blood (2022) 140 (Supplement 1): 6396–6398.
https://doi.org/10.1182/blood-2022-163849
Published: 2022
Journal Articles

A Prospective Multicenter Study of Minimal Residual Disease Assessment Using a Next-Generation Immunosequencing Assay and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, Jason R. Westin, Stephen J. Schuster, Grzegorz S. Nowakowski, Izidore S. Lossos, Devin Copley, Clare Grieve, Allison P. Jacob, Ashlee Joseph, Leana Laraque, Gita Masand, Chelsea D Mullins, Ellen Napier, Tania Rodriguez, Venkatraman Seshan, Shreya Vemuri, Andrew D. Zelenetz
Journal: Blood
Blood (2021) 138 (Supplement 1): 52.
https://doi.org/10.1182/blood-2021-150572
Published: 2021
Journal Articles

Interim Efficacy Analysis of a Phase II Study Demonstrates Promising Activity of the Combination of Pembrolizumab (PEM) and Entinostat (ENT) in Relapsed and Refractory (R/R) Hodgkin Lymphoma (HL)

David J. Sermer, Santosha Vardhana, Erin Biggar, Alison J. Moskowitz, Erel Joffe, Niloufer Khan, David J. Straus, Anita Kumar, Andrew D. Zelenetz, Steven M. Horwitz, Ariela Noy, Connie Lee Batlevi, Audrey Hamilton, Colette Owens, Matthew J. Matasar, M. Lia Palomba, Christina Y. Lee, Lorenzo Falchi, William T. Johnson, Heiko Schoder, Ahmet Dogan, Tira Bunyaviroch, Venkatraman Seshan, Gilles Salles, Anas Younes, Gottfried von Keudell
Journal: Blood
Blood (2021) 138 (Supplement 1): 2447.
https://doi.org/10.1182/blood-2021-154226
Published: 2021
Journal Articles

Preliminary Safety and Efficacy from a Multicenter, Investigator-Initiated Phase II Study in Untreated TP53 Mutant Mantle Cell Lymphoma with Zanubrutinib, Obinutuzumab, and Venetoclax (BOVen)

Anita Kumar, Jacob D. Soumerai, Jeremy S. Abramson, Connie Lee Batlevi, Puja Chadha, Ahmet Dogan, Lorenzo Falchi, Kelsey Flaherty, Chaya Friedman, Clare Grieve, Caleb Ho, P. Connor Johnson, Ashlee Joseph, Niloufer Khan, Joanna Mi, Rosalba Martignetti, Matthew J. Matasar, Colette Owens, Jade Ruiters, Sidney Sechio, Venkatraman Seshan, Elizabeth Simkins, Omar Abdel-Wahab, Andrew D. Zelenetz
Journal: Blood
Blood (2021) 138 (Supplement 1): 3540.
https://doi.org/10.1182/blood-2021-151831
Published: 2021
Journal Articles

Zanubrutinib, Obinutuzumab, and Venetoclax in Chronic Lymphocytic Leukemia: Early MRD Kinetics Define a High-Risk Patient Cohort with Delayed Bone Marrow Undetectable MRD and Earlier Post-Treatment MRD Recurrence

Jacob D. Soumerai, Anthony R. Mato, Ahmet Dogan, Venkatraman Seshan, Erel Joffe, Kelsey Flaherty, Jason Carter, Ephraim P Hochberg, Jeffrey A Barnes, Audrey Hamilton, Jeremy S. Abramson, Connie Lee Batlevi, Matthew J. Matasar, Ariela Noy, Colette Owens, M. Lia Palomba, Anita Kumar, Tak Takvorian, Ai Ni, Morgan Choma, Chaya Friedman, Puja Chadha, Elizabeth Simkins, Jade Ruiters, Sidney Sechio, Daneal Portman, Natascha Nolet, Neena Mahajan, Rosalba Martignetti, Joanna Mi, Krista J Scorsune, Julia M Lynch, Brianne McGree, Stephanie Y Hughes, Clare Grieve, Lindsey E. Roeker, Meghan C. Thompson, P. Connor Johnson, Mikhail Roshal, Jane Huang, Juliana M.L. Biondo, Jenny Qun Wu, Allison P. Jacob, Omar Abdel-Wahab, Andrew D. Zelenetz
Journal: Blood
Blood (2021) 138 (Supplement 1): 3753.
https://doi.org/10.1182/blood-2021-150961
Published: 2021
Journal Articles

Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition

Neeta Bala Tannan, Mandana T. Manzari, Laurie Herviou, Mariana Da Silva Ferreira, Connor Hagen, Hiroto Kiguchi, Katia Manova-Todorova, Venkatraman Seshan, Elisa de Stanchina, Daniel A. Heller, Anas Younes
Journal: Blood
Blood (2021) 137 (15): 2057–2069.
https://doi.org/10.1182/blood.2020008017
Published: 2021
Includes: Supplemental data
Journal Articles

R-CHOP Versus R-Bendamustine with or without Rituximab Maintenance in Newly Diagnosed Follicular Lymphoma Patients with High SUV at Baseline PET

Patrizia Mondello, MDPhDMSc, Paolo Strati, MD, Reid W Merryman, MD, Erel Joffe, MD MSc, Marco Ruella, MD, Venkatraman Seshan, PhD, Frederique St Pierre, Ajay Major, MDMBA, Priyanka Pophali, MD, Megan Fiasconaro, Carrie I Ho, MD, Eleanor Neal, Chao-Ming Lai, Gabriela Spilberg, MD, Saurabh Rajguru, MD, Jakub Svoboda, MD, Thomas E. Witzig, MD, Sonali M. Smith, MD, Philippe Armand, MD PhD, Loretta J. Nastoupil, MD, Stephen M. Ansell, MD PhD, Andrew D Zelenetz, MD PhD, Anas Younes, Gilles Salles
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-136438
Published: 2020
Journal Articles

Interim Analysis from a Prospective Multicenter Study of Next-Generation Sequencing Minimal Residual Disease Assessment and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, MD, Jason Westin, MD, Stephen J Schuster, MD, Grzegorz S. Nowakowski, MD, Izidore S. Lossos, MD, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Allison P. Jacob, Erel Joffe, MD MSc, Ashlee Joseph, Gottfried R. von Keudell, MD PhD, Leana Laraque, BA, Oscar B Lahoud, MD, Matthew J Matasar, MD, Craig H. Moskowitz, MD, Chelsea D Mullins, BS, Ariela Noy, MD, Colette Owens, MD, Maria Lia Palomba, Carol S. Portlock, MD, Ildefonso Rodriguez-Rivera, MD, Gilles Salles, MDPhD, Venkatraman Seshan, PhD, David J. Straus, MD, Shreya Vemuri, Anas Younes, Andrew D Zelenetz, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138889
Published: 2020
Journal Articles

Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of CNS Relapse Treated in the Rituximab Era

Sabela Bobillo, MD, Erel Joffe, MDMSc, Venkatraman Seshan, PhD, Ariela Noy, MD, Steven M. Horwitz, MD, M. Lia Palomba, MD, Matthew J Matasar, MD, David J. Straus, MD, Paul A. Hamlin, MD, Connie Lee Batlevi, MD PhD, Paola Ghione, MD, David Sermer, MD, Alison J. Moskowitz, MD, Audrey Hamilton, MD, Philip Caron, MD PhD, Colette Owens, MD, Gottfried R. von Keudell, MD PhD, Ahmet Dogan, MD PhD, Andrew D. Zelenetz, MD PhD, Anas Younes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1619.
https://doi.org/10.1182/blood-2019-131435
Published: 2019
Journal Articles

Incidence of Delayed Seromas and Related Risk of Bia-ALCL in a Cohort of 3521 Breast Cancer Women with Textured Implants Prospectively Followed Long Term

Paola Ghione, MD, Peter Cordeiro, MD, Venkatraman Seshan, PhD, Natasha Galasso, Nivetha Ganesan, MPH, Qunying Hu, Ahmet Dogan, MD PhD, Steven M. Horwitz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2842.
https://doi.org/10.1182/blood-2019-122572
Published: 2019
Journal Articles

Dual Inhibition of MCL1 and BCL2 in Lymphoma Using Tumor Targeted Nanoparticles

Neeta Bala Bala, PhD, Mandana Taghizadeh Manzari, PhD, Mariana Da Silva Ferreira, MSc, Zahra Asgari, Connor Hagen, Venkatraman Seshan, PhD, Elisa de Stanchina, Katia Manova-Todorova, Daniel Heller, Anas Younes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 305.
https://doi.org/10.1182/blood-2019-130571
Published: 2019
Journal Articles

Impact of PET Staging of Follicular Lymphoma on Treatment Outcomes and Prognosis

Anna Alperovich, MD, Connie L. Batlevi, MD PhD, Andrew M Intlekofer, MD PhD, Craig H. Moskowitz, MD, Steven M. Horwitz, MD, Andrew D. Zelenetz, MD PhD, Maria Lia Palomba, MD, Alison J. Moskowitz, MD, John Gerecitano, MD PhD, Paul A. Hamlin, MD, Matthew J. Matasar, MD, Craig S. Sauter, MD, Anita Kumar, MD, Ariela Noy, MD, David J. Straus, MD, Carol S. Portlock, MD, Audrey Hamilton, MD, Pamela Drullinsky, MD, Philip Caron, MD PhD, Ai Ni, PhD, Venkatraman Seshan, PhD, Anas Younes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1494.
https://doi.org/10.1182/blood.V130.Suppl_1.1494.1494
Published: 2017